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HIV researcher who specialised in HIV prevention for women. Born on April 8, 1956, in Kampala, Uganda, she died of complications from COVID-19 on March 31, 2020, outside Durban, South Africa, aged 63 years.

Gita Ramjee\'s professional mission was to make sure women, especially women from marginalised communities, were not overlooked in the HIV response. "She was a driving force behind HIV prevention among women", said Wafaa El-Sadr, the Director of ICAP at Columbia University, New York, USA. "She was keenly aware of the magnitude of the problem of HIV among women, particularly in southern Africa and that\'s what she devoted her life to." Best known for her research on the use of vaginal microbicides to help reduce the risk of HIV transmission, Ramjee also helped build a network of internationally renowned clinical research sites and was a key advocate for a holistic approach to HIV prevention for women. "She was passionate about HIV prevention, about human rights, but particularly about the rights of disadvantaged women", said Professor Gavin Churchyard, Group Chief Executive Officer (CEO) of the South Africa-headquartered Aurum Institute, where Ramjee worked as the Chief Scientific Officer. "She was committed to finding solutions."

Born in Kampala, Uganda, Ramjee\'s family was forced to flee when the dictator Idi Amin expelled all Asians from the country. She received a combined studies bachelor\'s degree in chemistry and physiology from the University of Sunderland in the UK, where she also met her husband, Pravin Ramjee. They moved to his home country, South Africa, in the 1980s. There she completed doctoral research on the role of proteinuria in childhood kidney diseases at what is now the University of KwaZulu-Natal (UKZN) in Durban under the guidance of Hoosen Coovadia, who is now the Emeritus Professor of Paediatrics and Child Health and Emeritus Victor Daitz Professor of HIV/AIDS Research at UKZN. "She was a very bright and alert person", Coovadia said. "She did her work flawlessly." Ramjee completed her doctorate in 1994 as South Africa\'s new post-apartheid government was beginning to grapple with the country\'s skyrocketing burden of HIV. She was invited to lead a study investigating the use of vaginal microbicides to prevent HIV transmission in sex workers. It set the path for her career. "That trial was my introduction to HIV prevention among high-risk populations", she said in an interview. "I learned about the dire need for women-initiated HIV prevention options and the sociobehavioral and cultural factors that impact women\'s lives."

Ramjee joined the South African Medical Research Council (SAMRC) in 1996, where she was at the forefront of HIV prevention research. She maintained an early focus on microbicides because she recognised that "women needed female-empowered technologies so they could take prevention into their own hands and protect themselves", said Glenda Gray, the President and CEO of SAMRC. Ramjee rose to become Chief Specialist Scientist and Director of SAMRC\'s HIV Prevention Research Unit, where she managed and did large-scale phase 3 trials in HIV prevention. She also oversaw the development of SAMRC\'s clinical trial unit, which "was critical for HIV prevention endeavours in South Africa", Gray said. "The clinical sites that Gita established were a huge resource at a global level." Ramjee\'s work gained her global recognition. "She had a tremendously big international network, where she was well respected and liked", Churchyard said.

Throughout her career, Ramjee positioned her research as part of a larger effort to improve women\'s health, including advocating for a holistic approach to HIV prevention that included reproductive health care. "She always had broader concerns about women\'s health, overall. The HIV prevention agenda fitted within her broader interests in women\'s health. The magnitude and impact \[of HIV\] made it the number 1 problem to tackle", El-Sadr said. Ramjee also pushed to increase the number of women in scientific research, serving as a mentor to aspiring researchers. "When I think of her legacy, I think of all the people she\'s trained all over the world", El-Sadr said. "Hopefully now they are going to continue to work to find successful HIV prevention tools."

Ramjee held honorary professorships at the University of Washington in Seattle, at the London School of Hygiene & Tropical Medicine, and at the University of Cape Town. In 2018, she received the European and Developing Countries Clinical Trials Partnership prize for Outstanding Female Scientist. "At the time she succumbed to her disease, she was an international figure in the world of HIV/AIDS", Coovadia said. "It was in the middle of an inspiring career." Ramjee is survived by her husband and her two sons, Shaniel and Rushil.
